Atlas Iron, QBE and Coca-Cola Amatil: Buy, hold or sell?

Look at the financial health of a business before parting with your hard-earned cash.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The stock market is stuck between 5,000 and 5,500 points looking for a reason to break out on either side of this trading range. Many investors may rightly question why our market remains a long way off its all-time high of 6,873 points when many other markets around the world are reaching new all time highs.

All we can do as investors is use the information we have available to make informed decisions as to which stocks to buy, hold or sell. Below are my personal recommendations. [Please note: As always, the opinions expressed on Fool.com.au are the writers' own and do not necessarily represent the opinion of Motley Fool Australia.]

Buy: Atlas Iron (ASX: AGO)

This is a favourite stock and sector of mine and one that I remain bullish on. Iron ore spot prices recently jumped to U.S. $116.90 a tonne. This price movement takes it back to the levels it was sitting at prior to the March 'flash crash'.

Atlas is my pick in the sector because it trails the performance of its rivals and to date I believe this is unjustified. Atlas has continued to meet and exceed guidance, has a debt-to-equity ratio of under 20% and is generating strong cash flows that can be used to pay off the remaining debt, grow the production capacity of the business or return funds to shareholders.

Trading at a price-to-earnings ratio of less than 9 and a price-to-book ratio of only just above 0.5, I think this stock appears a screaming buy. I expect the stock to trade back to $1.30 a share in the near to medium term and over $1.50 per share in the longer term depending on stability of the iron ore spot price.

Hold: QBE (ASX:QBE)

The great Warren Buffett loves insurance companies; he sees them as a huge pool of cash. I generally agree, but unfortunately for QBE shareholders the management team — once seen as a key strength of the business — has repeatedly disappointed the market. However it is looking increasingly likely that the new management team has taken a highly conservative view and swept out all the bad news in recent times.

Insurance margins have been consistently falling and the low interest rates in America have been to blame for the poor returns made on cash held by QBE in recent years. However this previous market darling could be on the road to recovery, and if so, the share price could quickly recover lost ground.

If the next reporting period indicates an improvement in insurance margins and financial performance, I will be carefully reconsidering my view on QBE.

Sell: Coca-Cola Amatil (ASX: CCL)

Many are viewing the recent price weakness in Coca-Cola Amatil's share price as a buying opportunity. I don't share this view. Coca-Cola Amatil has an exclusive license to the famous Coke syrup, which should almost be a license to print money. However the business has been reporting poor financial results and the guidance provided is not overly encouraging.

My main concern with Coca-Cola Amatil is that it is carrying significant debt. With a debt-to-equity ratio above 150%, it is one of the more highly debt-leveraged businesses operating on the ASX. Further, a pet peeve of mine is companies returning dividends to shareholders when they have significant debt balances. In my opinion, it is in the shareholders' interest to protect the long term viability of the business by maintaining a healthy balance sheet prior to the payment of dividends.

Cocal-Cola Amatil has a clear path to growth, which includes taking a larger market share of the alcoholic beverages market by utilising its extensive distribution network. Another growth option is the expanding presence in the wider Asia Pacific region. Until Coca-Cola Amatil cleans up the balance sheet and provides evidence it is able to best utilise its valuable assets, I feel it's a sell.

Foolish takeaway

The key ingredient when picking winning stocks is to stay away from dangerously high debt and buy into stocks that have a clear path to growth. Don't be fooled by dividend yields or strong brand names; look at the financial health of a business before parting with your hard-earned cash.

Motley Fool contributor Tim Roberts owns shares in Atlas Iron.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »